Skip to main content
JAMA Network logoLink to JAMA Network
. 2018 Jan 2;178(1):157. doi: 10.1001/jamainternmed.2017.7836

Imprecise Percentages

PMCID: PMC12527474  PMID: 29336536

In the article titled “The Supreme Court Ruling in Sandoz v Amgen: A Victory for Follow-on Biologics,”1 2 imprecise percentages in the first sentence of the second paragraph have been adjusted for accuracy. The article was corrected online.

Reference

  • 1.Sarpatwari A, Gluck AR, Curfman GD. The Supreme Court ruling in Sandoz v Amgen: a victory for follow-on biologics [published online November 13, 2017]. JAMA Intern Med. doi: 10.1001/jamainternmed.2017.6145 [DOI] [PubMed] [Google Scholar]

Articles from JAMA Internal Medicine are provided here courtesy of American Medical Association

RESOURCES